Breaking: US FDA Cancels Upcoming Adcomm Discussing 2025-2026 Flu Vaccine

 
• By Sarah Karlin-Smith and Derrick Gingery

The Vaccines and Related Biological Products Advisory Committee meeting next month was scheduled to select strains for the 2025-2026 flu vaccine. The cancellation could mean delays in vaccine availability.

Pharmacy with sign saying flu shot.
The FDA canceled a planned VRBPAC meeting to discuss flu vaccine strain selection for next season. (Shutterstock)

More from Vaccines

More from Product Reviews